Exicure, Inc.(XCUR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

XCUR Exicure, Inc.

Post-Market Trading 09-19 18:05:18 EDT

3.93

+1.64

+71.62%

盘后3.65

-0.28-7.07%

18:04 EDT

High6.00	Low3.46	Vol17.89M
Open5.64	D1 Closing2.29	Amplitude110.91%
Mkt Cap6.80M	Tradable Cap3.74M	Total Shares1.73M
T/O89.56M	T/O Rate1,880.27%	Tradable Shares951.38K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"XCUR","market":"US","secType":"STK","nameCN":"Exicure, Inc.","latestPrice":3.93,"timestamp":1726776000000,"preClose":2.29,"halted":0,"volume":17888577,"hourTrading":{"tag":"盘后","latestPrice":3.652,"preClose":3.93,"latestTime":"18:04 EDT","volume":50371,"amount":189889.50247799998,"timestamp":1726783488959},"delay":0,"floatShares":951384,"shares":1730240,"eps":-4.720433,"marketStatus":"Post-Market Trading","change":1.64,"latestTime":"09-19 18:05:18 EDT","open":5.64,"high":6,"low":3.4601,"amount":89559947.847888,"amplitude":1.109127,"askPrice":3.77,"askSize":450,"bidPrice":3.63,"bidSize":60,"shortable":3,"etf":0,"ttmEps":-4.720433,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1726790400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":2.29,"preHourTrading":{"tag":"盘前","latestPrice":5.6,"preClose":2.29,"latestTime":"09:29 EDT","volume":1493152,"amount":9603875.5721504,"timestamp":1726752599235},"postHourTrading":{"tag":"盘后","latestPrice":3.652,"preClose":3.93,"latestTime":"18:04 EDT","volume":50371,"amount":189889.50247799998,"timestamp":1726783488959},"volumeRatio":2.698652},"requestUrl":"/m/hq/s/XCUR/tweets","defaultTab":"tweets","newsList":[{"id":"2468048578","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2468048578","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468048578?lang=en_us&edition=fundamental","pubTime":"2024-09-19 19:45","pubTimestamp":1726746320,"startTime":"0","endTime":"0","summary":"Telesis Bio  shares increased nearly three-fold pre-bell, up nearly 198% Thursday following a 2.9% loss in the previous session.Zeo Energy  shares surged more than 168% after Wednesday's 8.8% drop.Exicure  shares more than doubled, up 162%, after the company said it secured a Nasdaq extension to show compliance with the exchange's listing rules.Galmed Pharmeceuticals  shares were up 47% after the company said it is expanding its drug development activities to cancer and major cardiometabolic diseases.Price: 4.0200, Change: +2.67, Percent Change: +197.78","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBIO","GLMD","ZEO","BK4096","XCUR","BK4121","BK7095","BK4139","ZEO.AU"],"gpt_icon":1},{"id":"2468525915","title":"Exicure Gets Nasdaq Extension to Show Compliance With Listing Rules; Share Almost Triple Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2468525915","media":"MT Newswires Live","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468525915?lang=en_us&edition=fundamental","pubTime":"2024-09-19 17:28","pubTimestamp":1726738135,"startTime":"0","endTime":"0","summary":"Exicure  said late Wednesday that a Nasdaq hearings panel granted an extension to continue its listing if the company can show by Nov. 14 evidence that it is complying with \"all applicable criteria for continued listing.\"The company is \"diligently\" working to satisfy the terms of the panel's requests in the agreed timeframe.The firm previously announced that it has regained compliance with the Nasdaq's minimum bid price requirement.Shares of the company soared 168% in premarket activity Thursday.Price: 6.1400, Change: +3.85, Percent Change: +168.12","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2095319765.USD","BK4585",".IXIC","NQmain","XCUR","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","BK4112","IE00B64PRP62.GBP","NDAQ","LU2210150020.SGD","BK4588","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"1194670059","title":"24H｜Nvidia and Tesla Gain Over 1%; Crypto Stocks Climb; Exicure Soars 169%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194670059","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194670059?lang=en_us&edition=fundamental","pubTime":"2024-09-19 09:50","pubTimestamp":1726710600,"startTime":"0","endTime":"0","summary":"U.S. stocks closed with modest losses on Wednesday, well off their intraday highs, after the Federal Reserve cut interest rates by 50 basis points, the high side of estimates for its first cut in more","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLSK","COIN","VERO","MARA","PGNY","SCS","XCUR","TSLA","MSTR","NVDA"],"gpt_icon":1},{"id":"2468797564","title":"Stocks to Watch: Steelcase, Progyny, America's Car-Mart, Exicure","url":"https://stock-news.laohu8.com/highlight/detail?id=2468797564","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468797564?lang=en_us&edition=fundamental","pubTime":"2024-09-19 07:51","pubTimestamp":1726703460,"startTime":"0","endTime":"0","summary":"Both Steelcase's second-quarter revenue and its third-quarter revenue outlook missed analyst expectations. The office-furniture company in its recent quarter posted revenue of $855.8 million, missing the $864.2 million that Wall Street analysts were looking for. For its current quarter, the Grand Rapids, Mich., company guided for revenue between $785 million and $810 million, below the $812.1 million that analysts polled by FactSet expect. Shares fall 12%, to $12.40, in after-hours trading.Progyny said a \"significant\" client, which accounted for approximately 670,000 of the company's members and 12% of its revenue in the first half of the year, will terminate its services agreement, effective Jan. 1. The New York company, which handles fertility care insurance coverage for employers, didn't name the client. It said it continues to anticipate an increase in its overall member count in 2025. Shares tumble 25%, to $18.24, in postmarket trading.Exicure was granted a Nasdaq listing extensio","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XCUR","BK4143","PGNY","BK4214","BK4154","CRMT","SCS"],"gpt_icon":1},{"id":"2468256639","title":"Exicure Shares More Than Double After Nasdaq Listing Extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2468256639","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468256639?lang=en_us&edition=fundamental","pubTime":"2024-09-19 06:30","pubTimestamp":1726698600,"startTime":"0","endTime":"0","summary":"Shares of Exicure surged in post-market trading after the company said it was granted a Nasdaq listing extension.The stock rose 167% to $6.11 from its regular session close of $2.29. That left the shares down 21% this year.The company said after the close it was granted an extension subject to showing compliance with all applicable listing criteria by Nov. 14. Shares rose 41% Monday after the company reported debt-for-equity exchange agreements with two promissory notes holders.Exicure last week said it regained compliance with the $1 minimum bid price requirement after previously disclosing several Nasdaq deficiency notices.In September 2022, the biotechnology company said it would suspend pre-clinical activities, halt all research and development, and would explore strategic alternatives to maximize stockholder value.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","PSQ","BK4112","IE00B3QW5Z07.USD","SQQQ","IE00BKPKM429.USD","QLD","BK4139","XCUR","BK4585",".IXIC","BK4588","IE00B64PRP62.GBP","IE00BGHQF748.EUR","MNQmain","TQQQ","LU2095319765.USD","LU2210149790.SGD","NDAQ","QID","NQmain"],"gpt_icon":1},{"id":"2468570105","title":"Exicure Granted Extension for Nasdaq Compliance Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2468570105","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468570105?lang=en_us&edition=fundamental","pubTime":"2024-09-19 04:50","pubTimestamp":1726692624,"startTime":"0","endTime":"0","summary":"Exicure ( ($XCUR) ) has provided an announcement. Exicure, Inc. has been granted an extension by the Nasdaq Hearings Panel to continue its listing,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exicure-granted-extension-for-nasdaq-compliance-deadline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exicure-granted-extension-for-nasdaq-compliance-deadline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","NDAQ","SQQQ","LU2095319765.USD","TQQQ","LU2210150020.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4588","QID","MNQmain","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","QLD","BK4585","PSQ","XCUR","BK4112",".IXIC"],"gpt_icon":0},{"id":"2468855204","title":"BRIEF-Exicure, Inc. Receives Extension From Nasdaq Hearings Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2468855204","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468855204?lang=en_us&edition=fundamental","pubTime":"2024-09-19 04:45","pubTimestamp":1726692330,"startTime":"0","endTime":"0","summary":"Exicure Inc   :   * EXICURE, INC. RECEIVES EXTENSION FROM NASDAQ HEARINGS PANELSource text for Eikon:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","MNQmain","IE00B64PRP62.GBP","BK4585","SQQQ","BK4112","BK4588","IE00BGHQF748.EUR","QLD","BK4139","NDAQ","LU2210150020.SGD","XCUR",".IXIC","LU2095319765.USD","TQQQ","QID","PSQ","NQmain","LU2210149790.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2468552883","title":"Exicure receives extension from Nasdaq hearings panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2468552883","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468552883?lang=en_us&edition=fundamental","pubTime":"2024-09-19 04:25","pubTimestamp":1726691148,"startTime":"0","endTime":"0","summary":"Exicure  said on Wednesday that Nasdaq Hearings Panel has granted an extension to continue the company’s listing subject to the company evidencing compliance with all applicable criteria by November 14, 2024.The company has regained compliance with Nasdaq’s minimum bid price requirement and exchanged approximately $1M of indebtedness for equity at a conversion price of $3 per share.","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/168634446/image_168634446.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/168634446/image_168634446.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4150919-exicure-receives-extension-from-nasdaq-hearings-panel","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["MNQmain","IE00B3QW5Z07.USD","BK4112","NQmain","BK4588","LU2210150020.SGD","SQQQ","XCUR","LU2210149790.SGD","IE00B64PRP62.GBP","PSQ","IE00BKPKM429.USD",".IXIC","TQQQ","QLD","BK4139","LU2095319765.USD","IE00BGHQF748.EUR","NDAQ","BK4585","QID","QQQ"],"gpt_icon":0},{"id":"2468551233","title":"Exicure, Inc. Receives Extension From Nasdaq Hearings Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2468551233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468551233?lang=en_us&edition=fundamental","pubTime":"2024-09-19 04:01","pubTimestamp":1726689697,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240918:nFWN3L00T3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2468543125","title":"Exicure, Inc. Receives Extension from Nasdaq Hearings Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2468543125","media":"Business Wire","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468543125?lang=en_us&edition=fundamental","pubTime":"2024-09-19 04:01","pubTimestamp":1726689660,"startTime":"0","endTime":"0","summary":"CHICAGO, September 18, 2024----Exicure, Inc.  , announced today that on September 17, 2024, the Company received notice that the Nasdaq Hearings Panel  granted an extension to continue the Company’s listing subject to the Company evidencing compliance with all applicable criteria for continued listing on The Nasdaq Capital Market by November 14, 2024. The Company is diligently working to timely satisfy the terms of the Panel’s requests and to ensure the Company’s continued listing on Nasdaq.As previously announced, the Company has regained compliance with Nasdaq’s minimum bid price requirement and exchanged approximately $1,000,000 of indebtedness for equity at a conversion price of $3.00 per share.Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its recent restructuring and suspension of clinical and development activities, the Company is exploring strat","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BpRuDnB2Yviuvu704.Fghg--~B/aD02MDA7dz0yNDMxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/82dc09912c72dfa0a12d50ca0646be16","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BpRuDnB2Yviuvu704.Fghg--~B/aD02MDA7dz0yNDMxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/82dc09912c72dfa0a12d50ca0646be16"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exicure-inc-receives-extension-nasdaq-200100990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID",".IXIC","NQmain","LU2210149790.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","MNQmain","SQQQ","IE00B3QW5Z07.USD","XCUR","NDAQ","BK4585","QLD","BK4112","TQQQ","IE00BGHQF748.EUR","PSQ","BK4139","BK4588","LU2095319765.USD","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2467819297","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2467819297","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467819297?lang=en_us&edition=fundamental","pubTime":"2024-09-16 19:32","pubTimestamp":1726486336,"startTime":"0","endTime":"0","summary":"NuCana  shares were up 200% pre-bell Monday after the company said that a combination of NUC-7738 and pembrolizumab led to prolonged progression-free survival in a phase 2 trial for patients with metastatic melanoma.Dermata Therapeutics  stock was over 64% higher following a 6.8% rise in the previous session.Exicure  shares were up 43%, adding to Friday's 5.3% increase.Agape ATP  stock was 26% higher, extending Friday's rally.Nuvalent  shares were up nearly 16% after Friday's 7.1% rise.Price: 7.6200, Change: +5.08, Percent Change: +200.00","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NCNA","NUVL","BK4139","XCUR","DRMA","BK4007","ATPC","BK4175","BK4539"],"gpt_icon":0},{"id":"2467987148","title":"Coda Octopus, RF Industries And 3 Stocks To Watch Heading Into Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2467987148","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467987148?lang=en_us&edition=fundamental","pubTime":"2024-09-16 14:29","pubTimestamp":1726468157,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/09/40871524/coda-octopus-rf-industries-and-3-stocks-to-watch-heading-into-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXR","BK4024","MNQmain","QID","CODA","BK4157","SQQQ","TQQQ","RFIL","BK4588","BK4211","BK4139","NQmain",".IXIC","BK4585","RF","QLD","BK4145","PSQ","VNCE","BK4202","XCUR"],"gpt_icon":1},{"id":"2467033893","title":"Stocks to Watch: Exicure, Volato Group, Canoo","url":"https://stock-news.laohu8.com/highlight/detail?id=2467033893","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467033893?lang=en_us&edition=fundamental","pubTime":"2024-09-14 06:47","pubTimestamp":1726267620,"startTime":"0","endTime":"0","summary":"Exicure entered debt-for-equity exchange agreements with two promissory notes holders. The Chicago biopharmaceuticals company agreed to issue 237,233 shares of its common stock to DGP, as well as 101,991 shares of its common stock to an individual promissory note holder. Both deals represent a conversion price of $3 a share. Shares surge 78%, to $2.85, in Friday's after-hours trading.Volato said that Honda Aircraft Co. has terminated its fleet purchase agreement. The private-jet ownership and flight-charters company after the bell on Friday said the fleet purchase agreement included the acquisition from Honda Aircraft of 23 HondaJet HA-420 aircraft for $161.6 million. The delivery dates had been set between the fiscal fourth quarter of 2023 and the fiscal fourth quarter of 2025. Shares fall 7%, to 45 cents, in postmarket trading.Canoo withdrew its 2024 revenue guidance along with guidance relating to its manufacturing run rate, production and delivery of vehicles in 2024 and subsequent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4008","GOEV","BK4139","XCUR","SOAR"],"gpt_icon":1},{"id":"2467872560","title":"BRIEF-Exicure- Got Notice From Nasdaq That It Has Regained Compliance With The Minimum Bid Price Requirement Under Nasdaq Listing Rule 5550(A)(2)","url":"https://stock-news.laohu8.com/highlight/detail?id=2467872560","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467872560?lang=en_us&edition=fundamental","pubTime":"2024-09-14 06:01","pubTimestamp":1726264867,"startTime":"0","endTime":"0","summary":"Exicure Inc   :   * EXICURE- GOT NOTICE FROM NASDAQ THAT IT HAS REGAINED COMPLIANCE WITH THE MINIMUM BID PRICE REQUIREMENT UNDER NASDAQ LISTING RULE 5550(A)(2)Source text for Eikon:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QID","XCUR","BK4567","LU0347712357.USD","MNQmain","LU2413666699.HKD","QLD","NQmain","LU1721428933.USD","A","PSQ","LU1165135440.EUR","IE00BGHQF748.EUR","BK4112","LU1543694498.USD","IE00BKPKM429.USD","LU2095319765.USD","LU2210150020.SGD","TQQQ","BK4139","BK4588","LU2413666426.HKD","SQQQ","LU2210149790.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4585","LU2041044095.USD",".IXIC","NDAQ","BK4121","LU2092937221.SGD"],"gpt_icon":1},{"id":"2467087617","title":"Exicure Shares Surge 78% on Debt-for-Equity Exchange Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2467087617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467087617?lang=en_us&edition=fundamental","pubTime":"2024-09-14 05:56","pubTimestamp":1726264560,"startTime":"0","endTime":"0","summary":"Shares of Exicure surged after the company entered debt-for-equity exchange agreements with two promissory notes holders.The stock jumped 78% to $2.84 in after-hours trading Friday. Shares, which hit a 52-week low of $1.44 during the regular session, are down 45% since the beginning of the year.The biopharmaceuticals company, based in Chicago, said in a Securities and Exchange Commission filing it agreed to issue 237,233 shares of its common stock to DGP, representing a conversion price of $3 a share.DGP is the company's largest shareholder, having owned approximately 35% of its outstanding shares ahead of this issuance.Exicure will issue an additional 101,991 shares of its common stock to an individual promissory note holder, also representing a conversion price of $3 a share.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","BK4585","EQR","BK4215","XCUR"],"gpt_icon":0},{"id":"2467086167","title":"Exicure- Got Notice From Nasdaq That It Has Regained Compliance With the Minimum Bid Price Requirement Under Nasdaq Listing Rule 5550(a)(2)","url":"https://stock-news.laohu8.com/highlight/detail?id=2467086167","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467086167?lang=en_us&edition=fundamental","pubTime":"2024-09-14 04:23","pubTimestamp":1726259010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240913:nFWN3KV0IT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XCUR"],"gpt_icon":0},{"id":"2466147390","title":"Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2466147390","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466147390?lang=en_us&edition=fundamental","pubTime":"2024-09-10 06:53","pubTimestamp":1725922380,"startTime":"0","endTime":"0","summary":"CHICAGO, September 09, 2024----Exicure, Inc.  announced today that it has entered into an agreement with plaintiffs to settle Colwell v. Exicure, Inc. et al., Case No. 1:21-CV-06637, a previously disclosed securities class action lawsuit pending in the United States District Court for the Northern District of Illinois . The settlement is subject to Court approval, and plaintiffs filed a motion for preliminary approval of the settlement with the Court on September 6, 2024.The settlement does not constitute any admission by the Company of any liability or wrongdoing. Nonetheless, the Company believes it is beneficial to resolve the case as further litigation would be burdensome and protracted.Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its recent restructuring and suspension of clinical and development activities, the Company is exploring strategic alt","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/YL9vxvghjbElQNMbE_THUw--~B/aD02MDA7dz0yNDMxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/69195881505446441c5fa77bc4b431d9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/YL9vxvghjbElQNMbE_THUw--~B/aD02MDA7dz0yNDMxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/69195881505446441c5fa77bc4b431d9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exicure-inc-announces-proposed-settlement-225300488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","XCUR"],"gpt_icon":0},{"id":"2463448367","title":"U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463448367","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463448367?lang=en_us&edition=fundamental","pubTime":"2024-08-29 05:35","pubTimestamp":1724880907,"startTime":"0","endTime":"0","summary":"Investing.com – U.S. stocks were lower after the close on Wednesday, as losses in the Technology, Consumer Services and Oil&Gas sectors led shares lower.At the close in NYSE, the Dow Jones Industrial Average lost 0.39%, while the S&P 500 index lost 0.60%, and the NASDAQ Composite index declined 1.14%.The best performers of the session on the Dow Jones Industrial Average were American Express Company , which rose 0.81% or 2.06 points to trade at 257.09 at the close. Meanwhile, Merck&Company Inc  added 0.80% or 0.93 points to end at 117.43 and Amgen Inc  was up 0.79% or 2.57 points to 329.50 in late trade.The worst performers of the session were Nike Inc , which fell 2.93% or 2.50 points to trade at 82.79 at the close. Intel Corporation  declined 2.29% or 0.46 points to end at 19.61 and Salesforce Inc  was down 1.96% or 5.17 points to 259.03.The top performers on the S&P 500 were Insulet Corporation  which rose 6.15% to 204.42, Bio-Rad Laboratories Inc  which was up 2.94% to settle at 32","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/u-stocks-lower-close-trade-213507286.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","WTO","SH","FBRX","IVV","SPY","DXD","TQQQ",".DJI","AMGN","UPRO","SDS","NKE","CRM","BBWI","UDOW","DJX","QLD","AXP",".IXIC","DDM","SPXU","OEF","NQmain",".SPX","DOG","PSQ","MNQmain","LU1861220207.SGD","VOO","INTC","BK4505","SQQQ","TSN","IE00BFTCPJ56.SGD","PODD","XCUR","OEX","BIO","ESmain","MRK","SDOW","SSO","SJM","COMP","ARBB","SMXT"],"gpt_icon":1},{"id":"2462591378","title":"Exicure Announces Reverse Stock Split and Shareholder Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=2462591378","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462591378?lang=en_us&edition=fundamental","pubTime":"2024-08-26 21:28","pubTimestamp":1724678895,"startTime":"0","endTime":"0","summary":"Exicure (XCUR) has shared an update. Exicure, Inc. has announced a one-for-five reverse stock split effective August 27, 2024, after obtaining shar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exicure-announces-reverse-stock-split-and-shareholder-approvals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exicure-announces-reverse-stock-split-and-shareholder-approvals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XCUR"],"gpt_icon":0},{"id":"2462599028","title":"BRIEF-Exicure Announces 1-For-5 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2462599028","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462599028?lang=en_us&edition=fundamental","pubTime":"2024-08-26 21:10","pubTimestamp":1724677859,"startTime":"0","endTime":"0","summary":"Aug 26 (Reuters) - Exicure Inc   :   * EXICURE, INC. ANNOUNCES 1-FOR-5 REVERSE STOCK SPLIT   * EXICURE INC -EXPECTS THAT REVERSE STOCK SPLIT WILL BECOME EFFECTIVE AT 5:00 PM ON TUESDAY, AUGUST 27Source text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XCUR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.exicuretx.com","stockEarnings":[{"period":"1week","weight":0.4774},{"period":"1month","weight":0.1583},{"period":"3month","weight":0.403},{"period":"6month","weight":-0.2714},{"period":"1year","weight":-0.4128},{"period":"ytd","weight":-0.2108}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0.0032},{"period":"3month","weight":0.0263},{"period":"6month","weight":0.0771},{"period":"1year","weight":0.2681},{"period":"ytd","weight":0.1811}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.004126},{"month":2,"riseRate":0.5,"avgChangeRate":-0.014116},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.133867},{"month":4,"riseRate":0.5,"avgChangeRate":0.033364},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.019668},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.007326},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.061979},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.041199},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.081637},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.077812},{"month":11,"riseRate":0.5,"avgChangeRate":-0.116496},{"month":12,"riseRate":0.5,"avgChangeRate":-0.056097}],"exchange":"NASDAQ","name":"Exicure, Inc.","nameEN":"Exicure, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Exicure, Inc.(XCUR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Exicure, Inc.(XCUR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Exicure, Inc.,XCUR,Exicure, Inc.股票,Exicure, Inc.股票老虎,Exicure, Inc.股票老虎国际,Exicure, Inc.行情,Exicure, Inc.股票行情,Exicure, Inc.股价,Exicure, Inc.股市,Exicure, Inc.股票价格,Exicure, Inc.股票交易,Exicure, Inc.股票购买,Exicure, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Exicure, Inc.(XCUR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Exicure, Inc.(XCUR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction